The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill.
Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Pawar DS, Hillard CJ, Rizzo JD, D'Souza A, Pasquini M, Coe CL, Irwin MR, Raison CL, Drobyski WR.
Knight JM, et al. Among authors: coe cl.
Transl Psychiatry. 2021 Jan 18;11(1):58. doi: 10.1038/s41398-020-01164-y.
Transl Psychiatry. 2021.
PMID: 33462203
Free PMC article.